References
- Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169(4):397–403.
- Hagberg H, David Edwards A, Groenendaal F. Perinatal brain damage: The term infant. Neurobiology of Disease. 2016;92(Pt A):102–112.
- Chalak LF, Rollins N, Morriss MC, et al. Perinatal acidosis and hypoxic-ischemic encephalopathy in preterm infants of 33 to 35 weeks’ gestation. The Journal of Pediatrics. 2012;160(3):388–394.
- Vannucci RC. Hypoxic-ischemic encephalopathy. Amer J Perinatol. 2000;17(03):113–120.
- Thornberg E, Thiringer K, Odeback A, et al. Birth asphyxia: incidence, clinical course and outcome in a Swedish population. Acta Paediatr. 1995;84(8):927–932.
- Shankaran S. Outcomes of hypoxic-ischemic encephalopathy in neonates treated with hypothermia. Clin Perinatol. 2014;41(1):149–159.
- Shankaran S, Pappas A, McDonald SA, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012; May 31366(22):2085–2092.
- Aly H, Khashaba MT, El-Ayouty M, et al. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006;28(3):178–182.
- Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1(6):489–495.
- Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11(10):700–714.
- Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148(1-2):213–227.
- Zhou W, Yuan J. Necroptosis in health and diseases. Semin Cell Dev Biol. 2014;35:14–23.
- Xu M, Zhang HL. Death and survival of neuronal and astrocytic cells in ischemic brain injury: a role of autophagy. Acta Pharmacol Sin. 2011;32(9):1089–1099.
- Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1(2):112–119.
- Nakajima T, Hata R, Kondo T, et al. Proteomic analysis of the hippocampus in naive and ischemic-preconditioned rat. J Neurol Sci. 2015;358(1-2):158–171.
- Linkermann A, Brasen JH, Himmerkus N, et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney International. 2012;81(8):751–761.
- Zhao H, Ning J, Lemaire A, et al. Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. Kidney International. 2015;87(4):738–748.
- Vieira M, Fernandes J, Carreto L, et al. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiology of Disease. 2014;68(C):26–36.
- Zhao H, Jaffer T, Eguchi S, et al. Role of necroptosis in the pathogenesis of solid organ injury. Cell Death Dis. 2015;6(11):e1975–e1975.
- Kanno H, Ozawa H, Tateda S, et al. Upregulation of the receptor-interacting protein 3 expression and involvement in neural tissue damage after spinal cord injury in mice. BMC Neurosci. 2015;16(1):62.
- Luedde M, Lutz M, Carter N, et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovascular Research. 2014;103(2):206–216.